Text Size
171 studies found for:    "Osteoporosis, Postmenopausal"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed
Has Results 		A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
22 Completed
Has Results 		A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
23 Completed A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: ibandronate [Bonviva/Boniva];   Drug: Risedronate
24 Completed A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP).
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
25 Recruiting Radius Loading in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
26 Recruiting Wellnara Post-marketing Surveillance in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2/LNG oral (Wellnara, BAY86-5029)
27 Completed Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate (HMR4003)
28 Completed Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: Teriparatide
29 Recruiting Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo
30 Completed Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Bazedoxifene;   Drug: Placebo
31 Active, not recruiting Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Condition: Post-menopausal Osteoporosis
Interventions: Drug: Ibandronate;   Drug: Risedronate;   Drug: Alendronate
32 Completed Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis Postmenopausal
Intervention: Drug: Risedronate (HMR4003)
33 Recruiting Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Liuwei Dihuang Pills
34 Active, not recruiting A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: denosumab;   Drug: placebo
35 Completed Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide;   Drug: Placebo;   Drug: Calcium Supplement;   Drug: Vitamin D Supplement
36 Terminated Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Risedronate;   Drug: Raloxifene;   Other: Placebo
37 Completed OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate sodium
38 Completed A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: MK0217, alendronate sodium / Duration of Treatment : 2 Years;   Drug: Comparator : calcium carbonate /Duration of Treatment : 2 Years
39 Completed Optimizing Body Composition & Health After Breast Cancer
Conditions: Breast Neoplasm;   Osteoporosis, Postmenopausal
Interventions: Behavioral: Resistance Exercise;   Behavioral: Flexibility Training
40 Completed Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
Conditions: Osteoporosis, Postmenopausal;   Osteopenia;   Falls
Interventions: Drug: alfacalcidol;   Drug: placebo
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years